FindTrial
Sign In

Exploring prophylactic co-trimoxazole regimens at the removal of temporary catheters to prevent urinary tract infections: a randomised placebo controlled pilot study

Exploring prophylactic co-trimoxazole regimens at the removal of temporary catheters to prevent urinary tract infections: a randomised placebo controlled pilot study - Exploring co-trimoxazole regimens

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON35979
Enrollment
42
Registered
2011-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cystitis urinarary tract infection

Interventions

Trimethoprim-sulfamethoxazole or placebo.

Sponsors

Spaarne Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Temporary urinary catheter for minimal 2 days Bacteriuria defined as more then 10^ 5 cfu/ ml Age of 18 years or older Signed informed consent

Exclusion criteria

Exclusion criteria: Antibiotic treatment of less than 1 week prior to the removal of the urinary catheter Urogenital surgery Pregnancy or breast feeding Known allergy to sulfamethoxazol or trimetoprim Renal insufficiency defined as MDRD less then 30ml/ minute Symptomatic urinary tract infection Co-medication interacting with sulfamethoxazole or trimetoprim upon discretion of the investigators

Design outcomes

Primary

MeasureTime frame
the course of the percentage of subjects with bacteriuria in seven days after intervention.—

Secondary

MeasureTime frame
the percentage of subjects with an urinary tract infection at any moment in seven days after intervention—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)